Life Biosciences launches a Phase I trial for cellular reprogramming to treat age-related macular degeneration, challenging aging norms with FDA’s Plausible Mechanism Pathway, amid rising invest...
A new multi-phase clinical trial on rapamycin aims to establish safe dosing for anti-aging, bridging the gap between off-label use and scientific validation in longevity medicine. Recent advancements ...
The ARMOR clinical trial investigates FMT from young, active donors to older adults to enhance muscle, cognitive, and metabolic health, addressing gut dysbiosis for aging resilience. A groundbreaking ...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
A new clinical trial explores time-restricted eating for Huntington’s disease, building on recent research showing benefits for mitochondrial function and autophagy. A groundbreaking clinical trial ...
A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and autophagy in early-stage Huntington’s disease patients. Groundbreaking research i...
A 12-week clinical trial at the University of Florida investigates time-restricted eating in early-stage Huntington’s disease, with potential benefits for mitochondrial function and cognitive pe...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
A 12-week clinical trial explores time-restricted eating’s effects on cognitive function and mitochondrial health in Huntington’s disease patients. New research investigates whether time-restr...
New clinical trial explores time-restricted eating’s potential benefits for Huntington’s disease patients, focusing on metabolic health and symptom management. A groundbreaking clinical tr...
